iwNHL 2018 Session V

Precision Medicine

In session V of iwNHL 2018, Anas Younes, MD, Franck Morschhauser, MD, PhD, Thomas Witzig, MD, and Davide Rossi, MD discuss the introduction of new precision medicines for lymphomas and other treatment methods.

Presentations
Introduction to Precision Medicine Trials in Lymphoma
Anas Younes
Memorial Sloan Kettering Cancer Center, New York City, NY
23 September, 2018

Anas Younes, MD, from Memorial Sloan Kettering Cancer Center, New York City, NY, gives us a talk on precision medicine trials in lymphoma.

Precision Medicine in Follicular Lymphoma
Franck Morschhauser
Centre Hospitalier RĂ©gional Universitaire de Lille, Lille, France
23 September, 2018

Franck Morschhauser, MD, PhD, from Centre Hospitalier RĂ©gional Universitaire de Lille, Lille, France, speaks on precision medicine in follicular lymphoma.

Precision Medicine Across Different Histologic Subtypes
Thomas Witzig
Mayo Clinic, Rochester, MI
23 September, 2018

Thomas Witzig, MD, from Mayo Clinic, Rochester, MI, talks about applying a precision medicine approach across different histological subtypes in lymphoma.

ctDNA to Guide Therapy
Davide Rossi
Institute of Oncology Research, Bellinzona, Switzerland
23 September, 2018

Davide Rossi, MD, from Institute of Oncology Research, Bellinzona, Switzerland, speaks on the role of circulating tumor DNA in guiding lymphoma treatments.